These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 132976)

  • 1. [Method of simultaneous determination of kallikrein, plasmin and thrombin precursors and inhibitors in human blood plasma].
    Gomazkov OA; Komissarova NV
    Biull Eksp Biol Med; 1976 May; 81(5):632-4. PubMed ID: 132976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relationship between the activity of the kallikrein, plasmin and thrombin systems of the blood during intense physical exertion].
    Gomazkov OA; Komissarova NV; Lantsberg LA
    Biull Eksp Biol Med; 1977 Nov; 84(11):521-3. PubMed ID: 145251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Levels of kallikrein, plasmin and thrombin precursors and the activity of their inhibitors in hypertension patients].
    Karpitskiĭ VV
    Vrach Delo; 1985 Aug; (8):37-40. PubMed ID: 3852574
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of plasma kallikrein selective inhibitors.
    Okada Y; Tsuda Y; Tada M; Wanaka K; Hijikata-Okunomiya A; Okamoto U; Okamoto S
    Biopolymers; 1999; 51(1):41-50. PubMed ID: 10380351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor.
    Rupin A; Mennecier P; Lila C; de Nanteuil G; Verbeuren TJ
    Thromb Haemost; 1997 Oct; 78(4):1221-7. PubMed ID: 9364988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serine protease specificity for peptide chromogenic substrates.
    Mattler LE; Bang NU
    Thromb Haemost; 1977 Dec; 38(4):776-92. PubMed ID: 146272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma prekallikrein: quantitative determination by direct activation with Hageman factor fragment (beta-XIIa).
    Alving BM; Tankersley DL; Mason BL
    J Lab Clin Med; 1983 Feb; 101(2):226-41. PubMed ID: 6549773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nature of the proteinase activated by the contact factor in human blood plasma].
    Veremeenko KN; Kizim AI; Lositskaia VM
    Vopr Med Khim; 1977; (3):391-6. PubMed ID: 196405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on assays for plasma prekallikrein and for the monitoring of coumarol therapy.
    Egberg N; Bergström K
    Haemostasis; 1978; 7(2-3):85-91. PubMed ID: 149049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel chromogenic peptide for prekallikrein/kallikrein determination.
    Huang WY; Wan X; Zhang S
    Clin Lab; 2009; 55(3-4):106-13. PubMed ID: 19462932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New synthetic inhibitors of C1r, C1 esterase, thrombin, plasmin, kallikrein and trypsin.
    Fujii S; Hitomi Y
    Biochim Biophys Acta; 1981 Oct; 661(2):342-5. PubMed ID: 6271224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic inhibitors of trypsin, plasmin, kallikrein, thrombin, C1r-, and C1 esterase.
    Tamura Y; Hirado M; Okamura K; Minato Y; Fujii S
    Biochim Biophys Acta; 1977 Oct; 484(2):417-22. PubMed ID: 143965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contact activation of human plasma prorenin in vitro.
    Blumberg AL; Sealey JE; Atlas SA; Laragh JH; Dharmgrongartama B; Kaplan AP
    J Lab Clin Med; 1981 Jun; 97(6):771-8. PubMed ID: 7014741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the reliability of plasminogen measurement employing the proactivator-activator converting method.
    Martin M
    Thromb Haemost; 1976 Dec; 36(3):551-65. PubMed ID: 138961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The state of prothrombin, plasminogen and fibrinogen in the newborn infant].
    Potron G; Droulle C; Behar C; Leroux B; Ledoyen MP; Mascre W
    Pathol Biol (Paris); 1975 Dec; 23 suppl():56-62. PubMed ID: 4759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of thrombin, plasmin and plasminogen activation by amidino compounds.
    Geratz JD
    Thromb Diath Haemorrh; 1970 Jun; 23(3):486-99. PubMed ID: 4247029
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of a chromatographic method for determining kallikrein and prekallikrein in dog blood serum].
    Dotsenko VL; Saiapin VN; Neshkova EA; Iarovaia GA
    Biull Eksp Biol Med; 1982 Aug; 94(8):117-20. PubMed ID: 6922725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prealbumin activator of prekallikrein. II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin.
    Kaplan AP; Austen KF
    J Exp Med; 1971 Apr; 133(4):696-712. PubMed ID: 4251126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of selective inhibitors against plasma kallikrein.
    Teno N; Wanaka K; Okada Y; Tsuda Y; Okamoto U; Hijikata-Okunomiya A; Naito T; Okamoto S
    Chem Pharm Bull (Tokyo); 1991 Nov; 39(11):2930-6. PubMed ID: 1839246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Septic shock in the rat: activation of plasma proteolytic systems and effects of a kallikrein inhibitor/bradykinin antagonist (S-2441).
    Högström H; Claeson G; Larsson-Backström C; Lundberg D; Wenngren E; Haglund U
    Acta Chir Scand; 1987 Mar; 153(3):161-4. PubMed ID: 3300117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.